Navigation Links
Covance Purchases Equity Stake in Caprion Proteomics
Date:12/16/2008

- New Biomarker VP Appointed

- BiomarkerCenter of Excellence Established in Greenfield, Indiana

PRINCETON, N.J.,Dec. 16/PRNewswire-FirstCall/ -- Covance Inc. (NYSE: CVD), a leading provider of drug development services, announced today that it has purchased a minority equity stake in Caprion Proteomics, the leading provider of proteomics-based services to the pharmaceutical industry, to further enhance its biomarker service offerings to clients.

Pursuant to terms of the agreement, Covance will serve as the exclusive contract research organization distributor of Caprion's proteomic biomarker services. In addition, Caprion will serve as Covance's exclusive proteomic discovery provider. Through this alliance, Covance and Caprion will offer pharmaceutical and biotechnology drug development customers a distinctive, innovative, and integrated biomarker solution.

Covance also announced today that it has hired a new vice president to lead its Biomarker Team and that it plans to establish a Biomarker Center of Excellence at its Greenfield, Indiana campus.

These strategic moves will enable Covance to further capitalize on the emerging high-growth service market in biomarker discovery, verification, validation, and deployment across the drug development continuum -- from early proof of concept through late-stage clinical trials and post-marketing surveillance. Currently, pharmaceutical companies are adopting biomarker strategies for the vast majority of new drug candidates, and it is predicted that within the next ten years biomarkers will be a standard aspect of drug development for any novel candidate. In fact, the U.S. FDA's 2006 Critical Path Initiative listed biomarkers as one of the two areas with the greatest impact on modernizing drug development and appr
'/>"/>

SOURCE Covance Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Covance and Lilly Finalize 10-Year, $1.6 Billion Strategic R&D Collaboration
2. Covance Decides to Pursue Its Original Preclinical Strategy in China
3. Covance and WuXi PharmaTech to Form a Joint Venture to Provide World-Class Preclinical Services in China
4. Covance to Present at The R.W. Baird 2008 Growth Stock Conference
5. Covance to Present at Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
6. Covance Reports Full-Year 2007 Revenue Growth Of 15.4% and Seventh Consecutive Year of EPS Growth in Excess of 20%
7. Covance Inc. Invites You to Join the Webcast of Its Third Quarter 2007 Financial Results Conference Call
8. Cell Therapeutics, Inc. Announces Single Institutional Investor Purchases $32.65 Million of Senior Convertible Notes
9. Cyprotex Purchases Applied Biosystems Sciex QTRAP(R) 5500 LC-MS/MS
10. Credit Suisse Repurchases Auction Rate Securities (ARS) From Rosetta Genomics
11. Cell Therapeutics, Inc. Announces Single Institutional Investor Purchases $24.7 Million of Senior Convertible Notes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)PHILADELPHIA, Dec. 3 Shire plc (LSE: SHP, Nasdaq: SHPGY ), the global specialty biopharmaceutical company, today announced a voluntary recall of five lots and voluntary market withdrawal of one lot
(Date:12/2/2009)COLUMBIA, Md., Dec. 2 Martek Biosciences Corporation (Nasdaq: MATK ) announced today that it intends to release the results of its fourth quarter and fiscal year 2009 on December 16, 2009, at approx
(Date:12/2/2009)NEW YORK, Dec. 2 Nearly 600 medical research executives, scientists, policy makers, and funders today convened to explore novel development approaches and innovative funding strategies at the inaugur
(Date:12/2/2009)LELYSTAD, The Netherlands, December 2 Pepscan Holding NV,the Netherlands based biotechnology company focusing on protein mimicking,technology for the generation of immune therapeutics today announced
Breaking Biology Technology:Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 2Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 3Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 4Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 5Martek to Announce Fourth Quarter and Fiscal Year 2009 Results 2Medical Research Leaders Explore Novel Strategies to Expedite the Search for Cures 2Dutch Biotech Company Pepscan Appoints New CEO 2
...ION OF VARIOUS FINANCIAL AND RESTRUCTURING ALTERNA...ire-FirstCall/ - Angiotech Pharmaceuticals, Inc. (...rmaceutical and medical device company, today anno...anagement (Ares) and New Leaf Venture Partners (Ne...e Purchase Agreement dated July 7, 2008. Angiotech...
...GO, Nov. 21 Gen-Probe,s (Nasdaq: GPRO ),CE-mark...ecular tool to more,accurately detect high-risk hu...iated with cervical cancer or precancerous lesions...entific posters presented last week by,independent...nference of the,European Research Organization on ...
...FF LAKE, N.J., Nov. 20 Par Pharmaceutical Compani....S. District Court for the District of New Jersey ...tion for a temporary restraining order (TRO) halti...budesonide inhaled solution). In conjunction with...d and that it too would halt all sales of its auth...
Other Biology Technology:Angiotech announces termination of note purchase agreement with Ares Management and New Leaf Venture Partners 2Angiotech announces termination of note purchase agreement with Ares Management and New Leaf Venture Partners 3Angiotech announces termination of note purchase agreement with Ares Management and New Leaf Venture Partners 4Promising Clinical Data on Gen-Probe's APTIMA(R) HPV Test Presented at Major European Medical Meeting 2Promising Clinical Data on Gen-Probe's APTIMA(R) HPV Test Presented at Major European Medical Meeting 3Promising Clinical Data on Gen-Probe's APTIMA(R) HPV Test Presented at Major European Medical Meeting 4Promising Clinical Data on Gen-Probe's APTIMA(R) HPV Test Presented at Major European Medical Meeting 5Par Pharmaceutical Halts Shipment of Budesonide Inhalation Suspension 2
(Date:12/4/2009)CORVALLIS, Ore. According to an analysis of statewide data taken from 1998-2001, women in Oregon who made less than $50,000 a year were more than three times likely to report they were discriminated
(Date:12/4/2009)The electroencephalogram (EEG) is widely used by physicians and scientists to study brain function and to diagnose neurological disorders. However, it has remained largely unknown whether the electrod
(Date:12/4/2009)A major discovery is challenging accepted thinking about amyloids the fibrous protein deposits associated with diseases such as Alzheimer,s and Parkinson,s and may open up a potential new area for t
Breaking Biology News(10 mins):Lower income women report more insurance-based discrimination during pregnancy, delivery 2How to read brain activity? 2New therapy targets for amyloid disease 2Climbing to new heights in the forest canopy 9503 1Climbing to new heights in the forest canopy 9503 2Sperm Cell Insights May Aid Stem Cell Research 53867 1Wrongful Death Lawsuit for Tyler R Hill Against Ambassadors Group docleaf et al Officially Settled 53862 1Wrongful Death Lawsuit for Tyler R Hill Against Ambassadors Group docleaf et al Officially Settled 53862 2Wrongful Death Lawsuit for Tyler R Hill Against Ambassadors Group docleaf et al Officially Settled 53862 3
...cher has found that sick female deer mice devote t...isa Schwanz, a researcher in the department of eco...e size of offspring for both infected and healthy ... with a parasite produced larger offspring than he...use most mammals tend to focus on their own surviv...
... Amyloid deposits in tissues and organs are linked...rkinsons, type II diabetes, and prion diseases suc...cal substances; they have potential as a nanomater...ecular assemblies exceed those of synthetic polyme...n the journal Angewandte Chemie, since the buildin...
...ission has awarded 4.5 million to a pan-European c...opes biological data resources into a sustainable,...ciences. The European Life-science Infrastructure ... by the European Molecular Biology Laboratorys Eur...lves 32 partners from 13 countries. The consortium...
Other Biology News:Mice mothers devote energies to offspring when life is threatened 2Protein fibrils as alternative plastics? 2Securing the future of Europe's biological data resources 2
Mouse Anti-Human B-Cells (FMC7 Antigen) Monoclonal Antibody, FITC Conjugated from AbD Serotec
... boxes are ideal for use in refrigerators, freezer...arious storage racks. Four vibrant colors allow fo...n the bottom allow liquid nitrogen drainage or pro....7 mm cell) grid which holds 81 tubes. Box dimen...
Rabbit Anti-PARATHION Polyclonal Antibody, Unconjugated from AbD Serotec
Rabbit Anti-Bacterial HISTIDASE Polyclonal Antibody, Unconjugated from AbD Serotec
Biology Products: